Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

BMC Neurology

Volumn 4, Issue , 2004, Pages

  Smith, Craig J ^a,b   Emsley, Hedley C A ^a,b   Gavin, Carole M ^b   Georgiou, Rachel F ^b   Vail, Andy ^a   Barberan, Elisa M ^b   del Zoppo, Gregory J ^c   Hallenbeck, John M ^d   Rothwell, Nancy J ^a   Hopkins, Stephen J ^b   Tyrrell, Pippa J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

C reactive protein; Inflammation; Interleukin 6; Outcome measures; Stroke acute

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

AGED; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

AGED; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BODY TEMPERATURE; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2642581809     PISSN: 14712377     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2377-4-2     Document Type: Article

References (45)

1. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ: Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000, 10:95-112.
2. Loddick SA, Turnbull AV, Rothwell NJ: Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1998, 18:176-179.
3. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F: Time course of IL-6 expression in experimental CNS ischemia. Neurol Res 1999, 21:287-292.
4. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995, 26:1393-1398.
5. Matsuda S, Wen T-C, Morita F, Otsuka H, Igase K, Yoshimura H, Sakanaka M: Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett 1996, 204:109-112.
6. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F: Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000, 31:1715-1720.
7. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995, 18:130-136.
8. Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T, Maiwald M, Werle E, Zorn M, Hengel H, Hacke W: Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998, 50:196-203.
9. Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Houth JG, Weber UJ, Pederson PM, Olsen TS: Early infection and prognosis after acute stroke: the Copenhagen stroke study. J Stroke Cerebrovasc Dis 2001, 10:217-221.
10. Ramadori G, Christ B: Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999, 19:141-155.
11. Luheshi G, Rothwell N: Cytokines and fever. Int Arch Allergy Immunol 1996, 109:301-307.
12. Chrousos GP: Seminars in medicine of the Beth Israel Hospital, Boston: the hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Eng J Med 1995, 332:1351-1362.
13. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M: Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994, 122:135-139.
14. Vila N, Castillo J, Dávalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31:2325-2329.
15. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V: Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 2001, 22:289-296.
16. Castellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, Dávalos A: Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002, 33:982-987.
17. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003, 34:1864-1870.
18. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG: Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999, 19:1004-1009.
19. Murros K, Fogelholm R, Kettunen S, Vuorela A-L: Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 1993, 116:12-17.
20. Chamorro A, Vila N, Ascaso C, Saiz A, Montalvo J, Alonso P, Tolosa E: Early prediction of stroke severity: role of the erythrocyte sedimentation rate. Stroke 1995, 26:573-576.
21. Czlonkowska A, Ryglewicz D, Lechowicz W: Basic analytical parameters as the predictive factors for 30-day case fatality rate in stroke. Acta Neurol Scand 1997, 95:121-124.
22. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999, 30:981-985.
23. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000, 31:410-414.
24. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001, 32:133-138.
25. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001, 32:917-924.
26. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D: Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002, 33:2459-2464.
27. Emsley HCA, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ: An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93-101.
28. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
29. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J, and the NINDS TPA Stroke Study Group: Improved reliability of the NIH Stroke Scale using video training. Stroke 1994, 25:2220-2226.
30. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
31. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965, 14:61-65.
32. Skriver EB, Olsen TS: Transient disappearance of cerebral infarcts on CT scan, the so-called fogging effect. Neuroradiology 1981, 22:61-65.
33. Kim JS, Yoon SS, Kim YH, Ryu JS: Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 1996, 27:1553-1557.
34. Ulich TR, del Castillo J, Guo K: In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood 1989, 73:108-110.
35. Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N, Mantovani A, Lazzarin A, Sozzani S, Poi G: Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998, 91:258-265.
36. Brett FM, Mizisin AP, Powell HC, Campbell IL: Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 1995, 54:766-775.
37. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998, 76:91-94.
38. Shalaby MR, Waage A, Aarden L, Espevik T: Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989, 53:488-498.
39. Allan SM, Rothwell NJ: Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001, 2:734-744.
40. Hallenbeck JM: The many faces of tumor necrosis factor in stroke. Nat Med 2002, 8:1363-1368.
41. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15:307-339.
42. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA: Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75:40-47.
43. Kammersgaard LP, Jörgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS: Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen stroke study. Stroke 2002, 33:1759-1762.
44. O'Neill PA, Davies I, Fullerton KJ, Bennett D: Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 1991, 22:842-847.
45. Fassbender K, Schmidt R, Mößner R, Daffertshofer M, Hennerici M: Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 1994, 25:1105-1108.